Hypertension, or high blood pressure, is one of the leading causes of cardiovascular disease, affecting over 1.28 billion adults worldwide according to the World Health Organization (WHO). Despite the availability of antihypertensive medications and lifestyle interventions, many individuals struggle with resistant hypertension—high blood pressure that remains uncontrolled despite the use of at least three antihypertensive drugs. For these patients, renal denervation (RDN) offers a promising minimally invasive solution. This article explores the mechanism of RDN, recent advancements in the field, and the effectiveness of this innovative procedure in reducing blood pressure.
